Showing results (11-20 of 75) with videos related to
Sort By:
Pageof 8
Methods in Molecular Biology (Clifton, N.J.)|August 8, 2024
Analysis of Mitophagy Reporters in DrosophilaAlvaro Sanchez-Martinez, Aitor Martinez, Alexander J WhitworthPlos Biology|August 3, 2023
FBXO7/ntc and USP30 antagonistically set the ubiquitination threshold for basal mitophagy and provide a target for Pink1 phosphorylation in vivoAlvaro Sanchez-Martinez, Aitor Martinez, Alexander J WhitworthCell Calcium|June 26, 2025
Calcium at the crossroads: TPC2's role in LRRK2-linked Parkinson's diseaseFederica De Lazzari, Simone Wanderoy, Alexander J WhitworthIscience|April 24, 2026
An optimized translating ribosome affinity purification protocol for low-abundance <i>Drosophila</i> tissuesLeonor Miller-Fleming, Wing Hei Au, Alexander J WhitworthDrug Discovery Today|March 15, 2006
Drosophila models pioneer a new approach to drug discovery for Parkinson's diseaseAlexander J Whitworth, Paul D Wes, Leo J PallanckCurrent Neurology and Neuroscience Reports|February 19, 2011
Molecular mechanisms of PINK1-related neurodegenerationJoe H Pogson, Rachael M Ivatt, Alexander J WhitworthPlos Genetics|October 21, 2020
Drosophila phosphatidylinositol-4 kinase fwd promotes mitochondrial fission and can suppress Pink1/parkin phenotypesAna Terriente-Felix, Emma L Wilson, Alexander J WhitworthHuman Molecular Genetics|August 8, 2015
VPS35 pathogenic mutations confer no dominant toxicity but partial loss of function in Drosophila and genetically interact with parkinBilal R Malik, Vinay K Godena, Alexander J WhitworthThe Biochemical Journal|December 24, 2025
Insights into PINK1/Parkin function and dysfunction from Drosophila modelsSeoyoung Park, Nikita Kozhushko, Thomas H Wight, et al.Antioxidants (Basel, Switzerland)|January 16, 2020
Antioxidant Therapy in Parkinson's Disease: Insights from <i>Drosophila melanogaster</i>Federica De Lazzari, Federica Sandrelli, Alexander J Whitworth, et al.Pageof 8